Synthesis and pharmacological evaluation of new cysLT 1 receptor antagonists

By Griera R.   Armengol M.   Reyes A.   Alvarez M.   Palomer A.   Cabre F.   Pascual J.   Garcia M.   Mauleon D.  

European Journal of Medicinal Chemistry, Vol. 32, Iss. 7, 1997-07 ,pp. : 547-570

Elsevier

Access to resources Recommend Favorite

Lung Function Improvement in Smokers Suffering from COPD with Zafirlukast, a CysLT₁-receptor Antagonist

By Cazzola M.   Boveri B.   Carlucci P.   Santus P.   DiMarco F.   Centanni S.   Allegra L.  

Pulmonary Pharmacology & Therapeutics, Vol. 13, Iss. 6, 2000-12 ,pp. : 301-305

Academic Press

Access to resources Recommend Favorite

Synthesis of 3- and 5'-substituted flavone-8-carboxylic acids as 'three-armed' leukotriene CysLT 1 receptor antagonists

By Zwaagstra M.E.   Korthouwer R.E.M.   Timmerman H.   Zhang M.-Q.  

European Journal of Medicinal Chemistry, Vol. 33, Iss. 2, 1998-02 ,pp. : 95-102

Elsevier

Access to resources Recommend Favorite

Cysteinyl leukotriene receptor CysLT₁ as a novel therapeutic target for allergic rhinitis treatment

By Shirasaki Hideaki  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 4, 2008-04 ,pp. : 415-423

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist

By Shibasaki M.   Fujimori A.   Takanashi M.   Kusayama T.   Tokioka T.   Satoh Y.   Okazaki T.   Uchida W.   Inagaki O.   Yanagisawa I.  

European Journal of Pharmacology, Vol. 335, Iss. 2, 1997-09 ,pp. : 167-173

Elsevier

Access to resources Recommend Favorite